This article has been updated to include a statement from Illumina.

NEW YORK (GenomeWeb News) - Life Technologies and several co-plaintiffs this week filed suit against Illumina for allegedly infringing three DNA-amplification patents.

The suit, filed in the US District Court for the District of Delaware, claims that Illumina and Solexa, which Illumina acquired in 2007, infringe US Patent Nos. 5,616,478; 5,989,698; and 6,001,568. All three patents relate to amplifying nucleic acids in a solid medium.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.

An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.

Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.

US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.